Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Substance Misuse To Psychiatric Disorders for Cannabis-Prospective Evaluation on Cognitive Function and Its Associated Genetic Vulnerability in Cannabis Users (SToP-C-PeCoG)

NCT04373525 is registered in ClinicalTrials.gov with The University of Hong Kong as lead sponsor.

NCT NCT04373525
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04373525 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Substance Misuse To Psychiatric Disorders for Cannabis-Prospective Evaluation on Cognitive Function and Its Associated Genetic Vulnerability in Cannabis Users (SToP-C-PeCoG)
Lead sponsor
The University of Hong Kong
Phase
Observational
Overall status
Completed
Start date
November 1, 2020
Completion date
December 31, 2025
Enrollment
110 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cannabis use, genetic predisposition, neurocognitive dysfunction